---
title: 'Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy
  in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian
  Cohort Study'
date: '2023-12-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38136287/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231223170641&v=2.18.0
source: heidelberg[Affiliation]
description: The optimal treatment approach in very-early and early-stage hepatocellular
  carcinoma (HCC) is not precisely defined, and there is ambiguity in the literature
  around the comparative efficacy of surgical resection versus ablation as curative
  therapies for limited disease. We performed this real-world propensity-matched,
  multi-centre cohort study to assess for differences in survival outcomes between
  those undergoing resection and those receiving ablation. Patients with Barcelona
  Clinic ...
disable_comments: true
---
The optimal treatment approach in very-early and early-stage hepatocellular carcinoma (HCC) is not precisely defined, and there is ambiguity in the literature around the comparative efficacy of surgical resection versus ablation as curative therapies for limited disease. We performed this real-world propensity-matched, multi-centre cohort study to assess for differences in survival outcomes between those undergoing resection and those receiving ablation. Patients with Barcelona Clinic ...